These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 22776563

  • 1. Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer.
    Yang XY, Li YX, Li M, Zhang L, Feng LX, Zhang N.
    Cancer Lett; 2013 Jul 01; 334(2):338-45. PubMed ID: 22776563
    [Abstract] [Full Text] [Related]

  • 2. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.
    Liu Y, Sun J, Cao W, Yang J, Lian H, Li X, Sun Y, Wang Y, Wang S, He Z.
    Int J Pharm; 2011 Dec 12; 421(1):160-9. PubMed ID: 21945183
    [Abstract] [Full Text] [Related]

  • 3. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
    Liu D, Liu Z, Wang L, Zhang C, Zhang N.
    Colloids Surf B Biointerfaces; 2011 Jul 01; 85(2):262-9. PubMed ID: 21435845
    [Abstract] [Full Text] [Related]

  • 4. Paclitaxel-loaded hyaluronan solid nanoemulsions for enhanced treatment efficacy in ovarian cancer.
    Kim JE, Park YJ.
    Int J Nanomedicine; 2017 Jul 01; 12():645-658. PubMed ID: 28176896
    [Abstract] [Full Text] [Related]

  • 5. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P, Wang H, Yu M, Liao Z, Wang X, Zhang F, Ji W, Wu B, Han J, Zhang H, Wang H, Chang J, Niu R.
    Eur J Pharm Biopharm; 2012 Jun 01; 81(2):248-56. PubMed ID: 22446630
    [Abstract] [Full Text] [Related]

  • 6. Hyaluronic acid derivative-modified nano-structured lipid carrier for cancer targeting and therapy.
    Liu X, Liu H, Wang SL, Liu JW.
    J Zhejiang Univ Sci B; 2020 Jul 01; 21(7):571-580. PubMed ID: 32633111
    [Abstract] [Full Text] [Related]

  • 7. Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs.
    Zhang L, Yao J, Zhou J, Wang T, Zhang Q.
    Int J Pharm; 2013 Jan 30; 441(1-2):654-64. PubMed ID: 23117024
    [Abstract] [Full Text] [Related]

  • 8. Ovarian cancer targeted hyaluronic acid-based nanoparticle system for paclitaxel delivery to overcome drug resistance.
    Wang L, Jia E.
    Drug Deliv; 2016 Jun 30; 23(5):1810-7. PubMed ID: 26530693
    [Abstract] [Full Text] [Related]

  • 9. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion.
    Liu Y, Zhou C, Wei S, Yang T, Lan Y, Cao A, Yang J, Hou Y.
    Colloids Surf B Biointerfaces; 2018 Oct 01; 170():330-340. PubMed ID: 29936386
    [Abstract] [Full Text] [Related]

  • 10. Improved safety and efficacy of a lipid emulsion loaded with a paclitaxel-cholesterol complex for the treatment of breast tumors.
    Ye J, Liu Y, Xia X, Meng L, Dong W, Wang R, Fu Z, Liu H, Han R.
    Oncol Rep; 2016 Jul 01; 36(1):399-409. PubMed ID: 27175803
    [Abstract] [Full Text] [Related]

  • 11. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution.
    Liu Y, Sun J, Lian H, Cao W, Wang Y, He Z.
    J Pharm Sci; 2014 May 01; 103(5):1538-47. PubMed ID: 24619562
    [Abstract] [Full Text] [Related]

  • 12. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel.
    Li J, Huo M, Wang J, Zhou J, Mohammad JM, Zhang Y, Zhu Q, Waddad AY, Zhang Q.
    Biomaterials; 2012 Mar 01; 33(7):2310-20. PubMed ID: 22166223
    [Abstract] [Full Text] [Related]

  • 13. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer.
    Wang F, Li L, Liu B, Chen Z, Li C.
    Biomed Pharmacother; 2017 Feb 01; 86():595-604. PubMed ID: 28027535
    [Abstract] [Full Text] [Related]

  • 14. Development and optimization of transferrin-conjugated nanostructured lipid carriers for brain delivery of paclitaxel using Box-Behnken design.
    Emami J, Rezazadeh M, Sadeghi H, Khadivar K.
    Pharm Dev Technol; 2017 May 01; 22(3):370-382. PubMed ID: 27689412
    [Abstract] [Full Text] [Related]

  • 15. Paclitaxel-loaded Nanolipidic Carriers with Improved Oral Bioavailability and Anticancer Activity against Human Liver Carcinoma.
    Harshita, Barkat MA, Rizwanullah M, Beg S, Pottoo FH, Siddiqui S, Ahmad FJ.
    AAPS PharmSciTech; 2019 Jan 23; 20(2):87. PubMed ID: 30675689
    [Abstract] [Full Text] [Related]

  • 16. Hyaluronic acid-coated nanostructured lipid carriers for loading multiple traditional Chinese medicine components for liver cancer treatment.
    Sun S, Guan Q, Shang E, Xiao H, Yu X, Shi L, Zhao C, Guo Y, Lv S, Li Y.
    Pak J Pharm Sci; 2020 Jan 23; 33(1):109-119. PubMed ID: 32122838
    [Abstract] [Full Text] [Related]

  • 17. Lung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect.
    Wang Y, Zhang H, Hao J, Li B, Li M, Xiuwen W.
    Drug Deliv; 2016 May 23; 23(4):1398-403. PubMed ID: 26079530
    [Abstract] [Full Text] [Related]

  • 18. Paclitaxel isomerisation in polymeric micelles based on hydrophobized hyaluronic acid.
    Smejkalová D, Nešporová K, Hermannová M, Huerta-Angeles G, Cožíková D, Vištejnová L, Safránková B, Novotný J, Kučerík J, Velebný V.
    Int J Pharm; 2014 May 15; 466(1-2):147-55. PubMed ID: 24614580
    [Abstract] [Full Text] [Related]

  • 19. Surface engineered nanostructured lipid carriers for targeting MDR tumor: Part II. In vivo biodistribution, pharmacodynamic and hematological toxicity studies.
    Negi LM, Talegaonkar S, Jaggi M, Verma AK, Verma R, Dobhal S, Kumar V.
    Colloids Surf B Biointerfaces; 2014 Nov 01; 123():610-5. PubMed ID: 25454755
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.